Gadobutrol and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Gadobutrol (gadobutrol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin Hydrochloride, and have Diabetes.

The phase IV clinical study analyzes which people have Weakness when taking Gadobutrol. It is created by eHealthMe based on reports of 811 people who have side effects when taking Gadobutrol from the FDA, and is updated regularly.

What is Gadobutrol?

Gadobutrol has active ingredients of gadobutrol. eHealthMe is studying from 811 Gadobutrol users. Check the latest studies of Gadobutrol.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,613 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 17, 2026

811 people reported to have side effects when taking Gadobutrol.
Among them, 33 people (4.07%) have Weakness.

Among these 33 people:

How long have people been on Gadobutrol when they have Weakness? *

What is the gender of people who have Weakness when taking Gadobutrol? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Weakness when taking Gadobutrol? *

What are other drugs people take besides Gadobutrol? *

Vitamin D3: 2 people, 6.06%
Calcium: 2 people, 6.06%
Prednisolone: 2 people, 6.06%
Metformin Hydrochloride: 2 people, 6.06%
Enbrel: 1 person, 3.03%
Meclizine: 1 person, 3.03%
Magnesium Oxide: 1 person, 3.03%
Magnesium: 1 person, 3.03%
Lipitor: 1 person, 3.03%
Lexapro: 1 person, 3.03%

What are other side effects people have besides Weakness? *

Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 9 people, 27.27%
Hypotension (abnormally low blood pressure): 9 people, 27.27%
Dizziness: 9 people, 27.27%
Dyspnea (difficult or laboured breathing): 8 people, 24.24%
Nausea (feeling of having an urge to vomit): 8 people, 24.24%
Rashes (redness): 7 people, 21.21%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 18.18%
Headache (pain in head): 6 people, 18.18%
Fatigue (feeling of tiredness): 5 people, 15.15%
Diarrhea: 5 people, 15.15%

What are the existing conditions these people have? *

Diabetes: 4 people, 12.12%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 9.09%
Metastases To Central Nervous System (cancer spreads to central nervous system): 2 people, 6.06%
Memory Loss: 2 people, 6.06%
High Blood Pressure: 2 people, 6.06%
Asthma: 1 person, 3.03%
Cataract (clouding of the lens inside the eye): 1 person, 3.03%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 3.03%
Constipation: 1 person, 3.03%
Dry Eyes (lack of adequate tears): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Gadobutrol and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gadobutrol:

Gadobutrol (811 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Gadobutrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,613 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadobutrol (the active ingredients of Gadobutrol) and Gadobutrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.